{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:09:23Z","timestamp":1783901363726,"version":"3.55.0"},"reference-count":19,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To examine Australian general practitioners\u2019 (GPs) perspectives on initiating oral anticoagulation for stroke prevention in patients with atrial fibrillation, and their approaches to monitoring medication adherence and persistence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study used semi-structured interviews with Australian GPs recruited from a large survey of anticoagulation practices. Interviews were conducted online, audio-recorded, transcribed verbatim and analysed using thematic analysis with inductive coding. Analysis was undertaken independently by multiple researchers, with consensus reached through team discussion. Interviews continued until thematic saturation was achieved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen GPs were interviewed. Initial management of atrial fibrillation and oral anticoagulation initiation varied, with limited access to echocardiography and cardiology services identified as key barriers, along with patient bleeding risk. Assessing and monitoring long-term adherence and persistence remained challenging, particularly among patients with low health literacy, cognitive impairment, polypharmacy and financial constraints. GPs used a range of strategies to monitor and improve adherence and persistence, such as patient education, supplemented by recall systems, multidisciplinary input and pharmacist involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Australian GPs report multiple challenges in initiating and monitoring anticoagulation for atrial fibrillation. Enabling GPs to confidently start oral anticoagulants without delaying for diagnostic testing\/cardiology review, improving access to echocardiography services, and supporting GPs to monitor adherence and persistence may help reduce stroke incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/py26067","type":"journal-article","created":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:41:26Z","timestamp":1783899686000},"source":"Crossref","is-referenced-by-count":0,"title":["Stroke prevention using oral anticoagulants among patients with atrial fibrillation: a qualitative study of Australian general practitioners"],"prefix":"10.1071","volume":"32","author":[{"given":"S.","family":"Wright","sequence":"first","affiliation":[{"name":"ASchool of Medicine, University of Notre Dame, Sydney, NSW, Australia."},{"name":"BDepartment of General Practice, School of Medicine, University of Notre Dame, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Hamed","sequence":"additional","affiliation":[{"name":"ASchool of Medicine, University of Notre Dame, Sydney, NSW, Australia."},{"name":"BDepartment of General Practice, School of Medicine, University of Notre Dame, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lowres","sequence":"additional","affiliation":[{"name":"CHeart Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-0336","authenticated-orcid":true,"given":"K.","family":"Giskes","sequence":"additional","affiliation":[{"name":"ASchool of Medicine, University of Notre Dame, Sydney, NSW, Australia."},{"name":"BDepartment of General Practice, School of Medicine, University of Notre Dame, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Orchard","sequence":"additional","affiliation":[{"name":"DSydney School of Public Health, The University of Sydney, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Freedman","sequence":"additional","affiliation":[{"name":"CHeart Research Institute, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-7728","authenticated-orcid":true,"given":"C.","family":"Hespe","sequence":"additional","affiliation":[{"name":"ASchool of Medicine, University of Notre Dame, Sydney, NSW, Australia."},{"name":"BDepartment of General Practice, School of Medicine, University of Notre Dame, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"2","key":"2026071219412181700_R1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology.","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"issue":"8","key":"2026071219412181700_R2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5694\/mja18.00646","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018.","volume":"209","author":"Brieger","year":"2018","journal-title":"Medical Journal of Australia"},{"issue":"9","key":"2026071219412181700_R3","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1161\/STROKEAHA.114.006070","article-title":"High prevalence of atrial fibrillation among patients with ischemic stroke.","volume":"45","author":"Friberg","year":"2014","journal-title":"Stroke"},{"key":"2026071219412181700_R4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.thromres.2021.10.025","article-title":"Reasons for non-adherence to thromboprophylaxis prescribing guidelines in atrial fibrillation in Western Australia: a qualitative descriptive study of general practitioners\u2019 views.","volume":"208","author":"Gebreyohannes","year":"2021","journal-title":"Thrombosis Research"},{"issue":"3","key":"2026071219412181700_R5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jep.13685","article-title":"Use of thromboprophylaxis guidelines and risk stratification tools in atrial fibrillation: a survey of general practitioners in Australia.","volume":"28","author":"Gebreyohannes","year":"2022","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"2026071219412181700_R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101443","article-title":"Time trends in stroke risk management among high-risk patients with non-valvular atrial fibrillation in Australia between 2011-2019.","volume":"53","author":"Giskes","year":"2024","journal-title":"IJC Heart & Vasculature"},{"key":"2026071219412181700_R7","first-page":"12","article-title":"Stroke risk mitigation. Prescribing and monitoring anticoagulation in atrial fibrillation.","volume":"25","author":"Giskes","year":"2024","journal-title":"Medicine Today"},{"key":"2026071219412181700_R8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-112305","article-title":"General Practitioner confidence and practices in oral anticoagulant use for atrial fibrillation in Australia: findings from a cross-sectional study.","volume":"16","author":"Hamed","year":"2026","journal-title":"BMJ Open"},{"issue":"2 Suppl","key":"2026071219412181700_R9","doi-asserted-by":"publisher","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines.","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"issue":"10","key":"2026071219412181700_R10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study.","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"issue":"10","key":"2026071219412181700_R11","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4070\/kcj.2019.0234","article-title":"Reducing stroke risk in atrial fibrillation: adherence to guidelines has improved, but patient persistence with anticoagulant therapy remains suboptimal.","volume":"49","author":"Lowres","year":"2019","journal-title":"Korean Circulation Journal"},{"issue":"1","key":"2026071219412181700_R12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1160\/TH15-04-0350","article-title":"Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.","volume":"115","author":"Martinez","year":"2016","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"2026071219412181700_R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026645","article-title":"Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016.","volume":"9","author":"Maura","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"2026071219412181700_R14","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-021-01590-x","article-title":"Patients\u2019 and clinicians\u2019 perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis.","volume":"22","author":"Osasu","year":"2021","journal-title":"BMC Family Practice"},{"issue":"4","key":"2026071219412181700_R15","doi-asserted-by":"publisher","DOI":"10.3399\/BJGPO.2021.0226","article-title":"Use of direct oral anticoagulants in primary care: a qualitative study integrating patient and practitioner perspectives.","volume":"6","author":"Osasu","year":"2022","journal-title":"BJGP Open"},{"issue":"11","key":"2026071219412181700_R16","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaf250","article-title":"Adherence to oral thromboprophylaxis in atrial fibrillation: an overview for clinicians.","volume":"27","author":"Potpara","year":"2025","journal-title":"Europace"},{"issue":"2","key":"2026071219412181700_R17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0038-1676835","article-title":"Improving the prescription of oral anticoagulants in atrial fibrillation: a systematic review.","volume":"119","author":"Pritchett","year":"2019","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"2026071219412181700_R18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gheart.2012.12.007","article-title":"Epidemiology of stroke: legacy of the framingham heart study.","volume":"8","author":"Romero","year":"2013","journal-title":"Global Heart"},{"key":"2026071219412181700_R19","unstructured":"The Royal Australian College of General Practitioners (2023) General Practice: Health of the Nation 2023. RACGP, East Melbourne."}],"container-title":["Australian Journal of Primary Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/doi\/10.1071\/PY26067\/1946154\/py26067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/doi\/10.1071\/PY26067\/1946154\/py26067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:41:28Z","timestamp":1783899688000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/py\/article\/32\/4\/PY26067\/274296\/Stroke-prevention-using-oral-anticoagulants-among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1071\/py26067","relation":{},"ISSN":["1448-7527","1836-7399"],"issn-type":[{"value":"1448-7527","type":"print"},{"value":"1836-7399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"PY26067"}}